PT Sejahteraraya Anugrahjaya (SRAJ) Fundamentals 2026 — Revenue Analysis | SniperIQ
PT Sejahteraraya Anugrahjaya (SRAJ) is a ID-listed Healthcare company in Medical - Care Facilities with a market capitalization of Rp134.63T, trading at Rp11000.00 on the JKT. This SniperIQ fundamentals page covers PT Sejahteraraya Anugrahjaya's valuation, profitability (net margin -10.7%), revenue (Rp2.59T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Sejahteraraya Anugrahjaya's market cap?
PT Sejahteraraya Anugrahjaya (SRAJ) has a market capitalization of approximately Rp134.63T, trading at Rp11000.00 on the JKT. Market cap moves with the live share price.
What is PT Sejahteraraya Anugrahjaya's P/E ratio?
PT Sejahteraraya Anugrahjaya's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 108.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is PT Sejahteraraya Anugrahjaya?
PT Sejahteraraya Anugrahjaya runs a net profit margin of -10.7%, a gross margin of 42.1%, and an operating margin of 3.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Sejahteraraya Anugrahjaya generate?
PT Sejahteraraya Anugrahjaya reported revenue of Rp2.59T for fiscal year 2025, with net income of -Rp199.0B and earnings per share (EPS) of -16.31. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Sejahteraraya Anugrahjaya pay a dividend?
PT Sejahteraraya Anugrahjaya does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Sejahteraraya Anugrahjaya financially healthy?
PT Sejahteraraya Anugrahjaya carries a debt-to-equity ratio of 3.81x and a current ratio of 1.45x, with a market beta of 0.41. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Sejahteraraya Anugrahjaya a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Sejahteraraya Anugrahjaya (SRAJ) the key facts are: market cap Rp134.63T, revenue Rp2.59T, 52-week range 4430-19200. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track PT Sejahteraraya Anugrahjaya's full fundamentals live
Get PT Sejahteraraya Anugrahjaya's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.